Mandelic acid

CAS No. 611-71-2

Mandelic acid( Mandelic acid, (R)- | Mandelic acid, D- )

Catalog No. M18892 CAS No. 611-71-2

It has the health function of killing sperm, reducing Yin, inhibiting bacteria, anti-inflammation and enhancing vagina self-cleaning.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 35 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mandelic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    It has the health function of killing sperm, reducing Yin, inhibiting bacteria, anti-inflammation and enhancing vagina self-cleaning.
  • Description
    Mandelic acid, (R)- is an aromatic alpha hydroxy acid. It is a white crystalline solid that is soluble in water and polar organic solvents. It is a useful precursor to various drugs. The molecule is chiral. The racemic mixture is known as paramandelic acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Mandelic acid, (R)- | Mandelic acid, D-
  • Pathway
    GPCR/G Protein
  • Target
    SGLT
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    611-71-2
  • Formula Weight
    152.14
  • Molecular Formula
    C8H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (657.25 mM)
  • SMILES
    C1=CC=C(C=C1)C(C(=O)O)O
  • Chemical Name
    (R)-2-hydroxy-2-phenylacetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bexagliflozin

    A potent and selective SGLT2 inhibitor with IC50 of 2 nM; shows little activity for SGLT1 (IC50=5.6 uM).

  • KGA-2727

    KGA-2727 is a potent and selective SGLT1 inhibitor, with Kis of 97.4 nM and 43.5 nM for human and rat SGLT1, respectively.?The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat).?KGA-2727 for the treatment of diabete.KGA-2727, which has a pyrazole-O-glucoside structure, as the first selective SGLT1 inhibitor.?

  • YM543

    A potent, selective and orally active SGLT2 inhibitor with IC50 of 8.9 nM, 280-fold selectivity over SGLT1.